Dr. Reddy's Laboratories, Haleon
Dr Reddy's completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP 458 million. This includes top brands like Nicotinell, Nicabate, Thrive, and Habitrol,
Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine replacement therapy (NRT) business for GBP 458 million. The deal includes brands like Nicotinell,
Dr. Reddy’s Acquires Global NRT Leader Nicotinell
Dr Reddy’s Laboratories (RDY) has released an update. Dr. Reddy’s Laboratories Ltd. has completed the acquisition of Haleon plc’s Nicotinell brand and related NRT products, expanding its consumer healthcare portfolio.
Dr Reddy’s invests $620 million in Swiss subsidiary for Nicotinell brand acquisition
Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned subsidiary, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment aligns with the company’s earlier board-approved fund infusion of up to ￡500 million ($640 million) to acquire the Nicotinell brand and related assets from the Haleon Group.
Dr. Reddy’s invests $620 mn in Swiss arm to acquire Haleon’s Nicotinell portfolio
Dr. Reddy's invests $620 million in Swiss subsidiary for acquisition of global nicotine replacement therapy brands from Haleon.
Dr. Reddy's Laboratories Completes $620-Million Investment In Switzerland Unit
The funds infused by the company into Dr. Reddy's SA will be used for the acquisition of Nicotinell and related brands.
Dr Reddy's Laboratories completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories on Monday said its Switzerland-based subsidiary has completed the acquisition of Haleon plc's global portfolio of consumer healthcare brands, outside of the US, in the Nicotine Replacement Therapy (NRT) category.
Dr Reddy's Acquires Haleon's NRT Portfolio
Dr Reddy's Laboratories has completed the acquisition of Haleon plc's global Nicotine Replacement Therapy (NRT) portfolio, including brands like Nicotinell, Nicabate, Thrive and Habitrol.
Business Line1d
Dr Reddy’s completes acquisition of Haleon Plc’s global portfolio of consumer healthcare brands in NRT
Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced ...
Benzinga.com7mon
Dr Reddy's Laboratories (NYSE:RDY) Stock Quotes, Forecast and News Summary
Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's ...
Morningstar4d
Dr Reddy's Laboratories Ltd ADR RDY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Dr Reddy's completes acquisition of Haleon's global NRT portfolio
DRL's Swiss subsidiary completed the acquisition through the purchase of shares of Northstar Switzerland SARL, a Haleon group ...